0001745285-19-000002.txt : 20190103
0001745285-19-000002.hdr.sgml : 20190103
20190103165912
ACCESSION NUMBER: 0001745285-19-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190102
FILED AS OF DATE: 20190103
DATE AS OF CHANGE: 20190103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WIINBERG ULF
CENTRAL INDEX KEY: 0001187314
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29089
FILM NUMBER: 19506568
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGENUS INC
CENTRAL INDEX KEY: 0001098972
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 061562417
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-674-4410
MAIL ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIGENICS INC /DE/
DATE OF NAME CHANGE: 19991115
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-01-02
0
0001098972
AGENUS INC
AGEN
0001187314
WIINBERG ULF
C/O AGENUS INC.
3 FORBES ROAD
LEXINGTON
MA
02421
1
0
0
0
Deferred Shares
2.125
2019-01-02
4
A
0
7940.88
2.125
A
Common Stock
7940.88
7940.88
D
Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.
Evan D. Kearns, by Power of Attorney
2019-01-03